Features of natural and gonadotropin-releasing hormone antagonist-induced corpus luteum regression and effects of in vivo human chorionic gonadotropin
Author
dc.contributor.author
Del Canto, Felipe
Author
dc.contributor.author
Sierralta, Walter
Author
dc.contributor.author
Kohen Skop, Paulina
Author
dc.contributor.author
Ferrada Muñoz, Alex Eduardo
Author
dc.contributor.author
Strauss, Jerome F.
Author
dc.contributor.author
Devoto, Luigi
Admission date
dc.date.accessioned
2019-03-11T12:54:57Z
Available date
dc.date.available
2019-03-11T12:54:57Z
Publication date
dc.date.issued
2007
Cita de ítem
dc.identifier.citation
Journal of Clinical Endocrinology and Metabolism, Volumen 92, Issue 11, 2018, Pages 4436-4443
Identifier
dc.identifier.issn
0021972X
Identifier
dc.identifier.issn
0021972X
Identifier
dc.identifier.other
10.1210/jc.2007-0125
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164416
Abstract
dc.description.abstract
Context: The natural process of luteolysis and luteal regression is induced by withdrawal of gonadotropin support. Objective: The objectives of this study were: 1) to compare the functional changes and apoptotic features of natural human luteal regression and induced luteal regression; 2) to define the ultrastructural characteristics of the corpus luteum at the time of natural luteal regression and induced luteal regression; and 3) to examine the effect of human chorionic gonadotropin (hCG) on the steroidogenic response and apoptotic markers within the regressing corpus luteum. Design: Twenty-three women with normal menstrual cycles undergoing tubal ligation donated corpus luteum at specific stages in the luteal phase. Some women received a GnRH antagonist prior to collection of corpus luteum, others received an injection of hCG with or without prior treatment with a GnRH antagonist. Main Outcome Measure: Main outcome measures were plasma hormone levels and analysis of excised luteal t